Clinical Trial Update: Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular [Phase 2]

View source ↗

Summary

Phase 2a study evaluating safety and efficacy of PH100 tablet in type 2 diabetes mellitus with circulatory complication has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus with Circulatory Complication

Drugs mentioned

• PH100

Snippet

Sponsor: Bota Bio Co., Ltd. | Conditions: Type 2 Diabetes Mellitus With Circulatory Complciation | Phase 2 | Status: COMPLETED